There is robust evidence that the activation of the PD-1 receptor in microglia via PD-L1 signaling can suppress neuroinflammation in many pathological conditions, such as ischemic stroke, traumatic brain injury, Alzheimer’s disease, and multiple sclerosis [52, 53, 60, 61]. Here, CD274 is linked to Alzheimer disease.